Advanced search
Publication Cover
Cancer Management and Research Volume 14, 2022 - Issue
Submit an article Journal homepage
227
Views
1
CrossRef citations to date
0
Altmetric
Original Research

The Overexpression and Clinical Significance of AP1S1 in Breast Cancer

Danni Zheng1 Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaView further author information
,
Weida Fu1 Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaView further author information
,
Lingli Jin1 Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaView further author information
,
Xiaofang Jiang2 Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaView further author information
,
Wenjie Jiang1 Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaView further author information
,
Yaoyao Guan3 Department of Plastic Surgery, Sir Run-Run Hospital Affiliated to Zhejiang University, Hangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Rutian Hao1 Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1475-1492 | Published online: 16 Apr 2022

References

  • Siegel R, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA: Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.21654
  • Pfeiffer R, Webb-Vargas Y, Wheeler W, et al. Proportion of U.S. Trends in breast cancer incidence attributable to long-term changes in risk factor distributions. Cancer Epidemiol Biomark Prev. 2018;27(10):1214–1222. doi:10.1158/1055-9965.EPI-18-0098
  • Moo T, Sanford R, Dang C, et al. Overview of breast cancer therapy. PET Clin. 2018;13(3):339–354
  • Bonifacino J, Glick BJC. The mechanisms of vesicle budding and fusion. Cell. 2004;116(2):153–166. doi:10.1016/s0092-8674(03)01079-1
  • Robinson MS. Adaptable adaptors for coated vesicles. Trends Cell Biol. 2004;14(4):167–174.
  • Owen D, Collins BM, Evans PR, et al. Adaptors for clathrin coats: structure and function. Ann Rev cell Develop Biol. 2004;20:153–191. doi:10.1146/annurev.cellbio.20.010403.104543
  • Bonifacino JS. Adaptor proteins involved in polarized sorting. J Cell Biol. 2014;204(1):7–17.
  • Montpetit A, Côté S, Brustein E, et al. Disruption of AP1S1, causing a novel neurocutaneous syndrome, perturbs development of the skin and spinal cord. PLoS Gene. 2008;4(12):e1000296. doi:10.1371/journal.pgen.1000296
  • Meyer C, Zizioli D, Lausmann S, et al. mu1A-adaptin-deficient mice: lethality, loss of AP-1 binding and rerouting of mannose 6-phosphate receptors. EMBO J. 2000;19(10):2193–2203. doi:10.1093/emboj/19.10.2193
  • Klee K, Janecke AR, Civan HA, et al. AP1S1 missense mutations cause a congenital enteropathy via an epithelial barrier defect. Hum Genet 2020;139(10):1247–1259.
  • Martinelli D, Dionisi-Vici C. AP1S1 defect causing MEDNIK syndrome: a new adaptinopathy associated with defective copper metabolism. Ann N Y Acad Sci. 2014;1314:55–63. doi:10.1111/nyas.12426
  • Hu Frisk JM, Kjellén L, Kaler SG, et al. Copper regulates maturation and expression of an MITF:Tryptase axis in mast cells. J Immunol. 2017;199(12):4132–4141. doi:10.4049/jimmunol.1700786
  • Martinelli D, Travaglini L, Drouin CA, et al. MEDNIK syndrome: a novel defect of copper metabolism treatable by zinc acetate therapy. Brain. 2013;136:872–881. doi:10.1093/brain/awt012
  • Sun Y, Cao F-L, Qu -L-L, et al. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1. Eur Rev Med Pharmacol Sci. 2019;23(4):1459–1467. doi:10.26355/eurrev_201902_17103
  • Yun W, Hu Y-M, Zhao C-B, et al. HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway. Eur Rev Med Pharmacol Scii. 2019;23(7):2786–2793. doi:10.26355/eurrev_201904_17553
  • Kou Y, Yan X, Liu Q, et al. HBV upregulates AP-1 complex subunit mu-1 expression via the JNK pathway to promote proliferation of liver cancer cells. Oncol Letters. 2019;18(1):456–464. doi:10.3892/ol.2019.10291
  • Takahashi D, Hase K, Kimura S, et al. The epithelia-specific membrane trafficking factor AP-1B controls gut immune homeostasis in mice. Gastroenterology. 2011;141(2):621–632. doi:10.1053/j.gastro.2011.04.056
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Boehm M, Bonifacino JS. Adaptins: the final recount. Mol Biol Cell. 2001;12(10):2907–2920. doi:10.1091/mbc.12.10.2907
  • Candiello E, Kratzke M, Wenzel D, et al. AP-1/σ1A and AP-1/σ1B adaptor-proteins differentially regulate neuronal early endosome maturation via the Rab5/Vps34-pathway. Sci Rep. 2016;6:29950. doi:10.1038/srep29950
  • Candiello E, Mishra R, Schmidt B, et al. Differential regulation of synaptic AP-2/clathrin vesicle uncoating in synaptic plasticity. Sci Rep. 2017;7(1):15781. doi:10.1038/s41598-017-16055-4
  • Kim R, Emi M, Tanabe KJI. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121(1):1–14. doi:10.1111/j.1365-2567.2007.02587.x
  • Iwasaki A, Medzhitov RJS. Regulation of adaptive immunity by the innate immune system. Science. 2010;327(5963):291–295. doi:10.1126/science.1183021
  • Finn OJ. Cancer immunology. New Engl J Med. 2008;358(25):2704–2715. doi:10.1056/NEJMra072739
  • Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis. 1999;5(4):285–294. doi:10.1097/00054725-199911000-00009
  • Banchereau J, Steinman RJN. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245–252. doi:10.1038/32588
  • Kaliński P, Hilkens CM, Wierenga EA, et al. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today. 1999;20(12):561–567. doi:10.1016/s0167-5699(99)01547-9
  • O’Shea J, Paul WJS. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science. 2010;327(5969):1098–1102. doi:10.1126/science.1178334

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.